Ikarian Capital, LLC Neuronetics, Inc. Transaction History
Ikarian Capital, LLC
- $328 Million
- Q2 2025
A detailed history of Ikarian Capital, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 1,099,700 shares of STIM stock, worth $3.46 Million. This represents 1.17% of its overall portfolio holdings.
Number of Shares
1,099,700
Previous 1,100,000
0.03%
Holding current value
$3.46 Million
Previous $4.05 Million
5.21%
% of portfolio
1.17%
Previous 0.57%
Shares
2 transactions
Others Institutions Holding STIM
# of Institutions
97Shares Held
18.6MCall Options Held
49.6KPut Options Held
78.8K-
Vanguard Group Inc Valley Forge, PA2.74MShares$8.64 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$5.48 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.51MShares$4.75 Million0.01% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$3.15 Million0.14% of portfolio
-
Manatuck Hill Partners, LLC Westport, CT920KShares$2.9 Million1.29% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $85.1M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...